How to Use anti-obesity in a Sentence

anti-obesity

adjective

• These are key questions in the debate over the new anti-obesity drugs.
  — Heather Wilhelm, National Review, 22 Feb. 2024
• In fact, people have a wide range of responses to anti-obesity medicines.
  — Emily Mullin, WIRED, 1 July 2024
• Safety problems in the 1990s with the anti-obesity treatment known as fen-phen, which had to be withdrawn from the market, were also fresh in their minds.
  — Amanda Seitz, Fortune, 28 Dec. 2023
• Weight Watchers) and Noom are now prescribing these anti-obesity meds as part of their weight loss programs.
  — Lipi Roy, Md, Forbes, 29 Feb. 2024
• And doctors say people shouldn't take these anti-obesity medications just to drop a few pounds.
  — Karen Weintraub, USA TODAY, 22 Mar. 2023
• For type 2 diabetics, this is used for long-term weight management and is an anti-obesity drug.
  — Amber Smith, Discover Magazine, 25 Sep. 2023
• Sharp said the program is collaborating with community health centers in the city and with Froedtert Health to get the word out about the anti-obesity program.
  — Sarah Volpenhein, Journal Sentinel, 26 July 2024
• In 2003, Arkansas became the first state to send home BMI reports about all students as part of a broader anti-obesity initiative.
  — Kavitha Cardoza, CNN, 12 Apr. 2024
• Since Wegovy has only been on the market as an anti-obesity drug since 2021, there’s some uncertainty about its long-term effects.
  — Sarah Sloat, Health, 30 Mar. 2023
• The paper showed that people taking the drug lost on average 15 percent of their body weight—a level of weight loss practically unheard-of for an anti-obesity medicine.
  — Matt Reynolds, WIRED, 7 July 2023
• The first group was prescribed semaglutide, while the second was prescribed anti-obesity drugs that weren’t GLP-1 receptor agonists.
  — Aria Bendix, NBC News, 15 Apr. 2024
• In the 1990s, another popular anti-obesity medication known as fen-phen was sold en masse, but the FDA withdrew approval when doctors linked the drug to heart defects.
  — Nina Baker, The Courier-Journal, 23 July 2024
• Large pharma companies like Roche and Pfizer are also working on their own anti-obesity drugs.
  — Bruce Gil, Quartz, 4 Sep. 2024
• Novo has struggled to keep up with soaring demand for the appetite-suppressing anti-obesity drug, and has limited the number of U.S. patients who can start treatment since May.
  — Ed Silverman, STAT, 2 Nov. 2023
• Last year, the influential group added anti-obesity medications as part of its guidelines for treating obesity in kids ages 12 and up.
  — Marina Kopf, NBC News, 21 Feb. 2024
• In other words, the more effective anti-obesity drugs become, the more insurance providers might realize their value.
  — Laura Hensley, Verywell Health, 11 Jan. 2024
• Aloe vera gel may have lipid-lowering and anti-obesity effects that may help people lose weight.14 Much of the research on aloe vera for fat loss is dated or mostly only in animals.
  — Elizabeth Barnes, Verywell Health, 10 Sep. 2024
• Should Medicare cover the new generation of anti-obesity drugs?
  — Heather Wilhelm, National Review, 22 Feb. 2024
• After all, Wall Street analysts are predicting as much as $100 billion in annual revenue to be made from anti-obesity medications in the next six years.
  — Will Daniel, Fortune, 10 July 2024
• In 2021, Novo Nordisk received approval for Wegovy, which has the same active ingredient as Ozempic but comes with a higher maximum dose, as an anti-obesity drug.
  — Jia Tolentino, The New Yorker, 20 Mar. 2023
• Those whose commercial insurance doesn’t cover anti-obesity medications can get a $500 discount on the full price for Wegovy.
  — Tami Luhby, CNN, 15 Feb. 2024
• The American Academy of Pediatrics included anti-obesity drugs for the first time this year in its guidelines for treating childhood obesity.
  — Akshay Syal, M.d., NBC News, 19 July 2023
• Arming more doctors and health professionals with the right tools for selecting the right anti-obesity therapies could finally turn the obesity curve around and bring more people to manageable, long-term weight control.
  — Alice Park, Time, 30 June 2023
• The European Medicines Agency started investigating the issue in July after reports of suicidal thoughts and self-harm from people who had been taking the anti-obesity drugs.
  — Deirdre Hipwell, Fortune, 2 Dec. 2023
• In January, North Carolina cut off coverage of anti-obesity medicines for state employees, citing soaring costs and lack of agreement on pricing from drugmakers.
  — Madison Muller, Fortune Europe, 28 Mar. 2024
• The program, developed by a team of scientists, dietitians, fitness experts and others specializing in obesity, is designed to help members use the new anti-obesity medications, which can lead to rapid changes in weight.
  — Anne Marie Lee, CBS News, 15 Dec. 2023
• Researchers are now racing to develop new anti-obesity medications that are more effective, more convenient, or produce fewer side effects than the ones currently on the market.
  — Emily Mullin, WIRED, 24 July 2024
• While anti-obesity medications are beneficial to heart health in some ways, some drugs like Wegovy (Semaglutide), may also increase your heart rate and cause other cardiovascular issues.
  — David Snyder, Verywell Health, 30 Mar. 2024
• North Carolina is cutting off coverage of anti-obesity medications for state employees, citing soaring costs and a lack of agreement on pricing from drugmakers.
  — Simone Foxman, Fortune, 27 Jan. 2024
• Analysts at Goldman Sachs on Tuesday published research highlighting 54 anti-obesity drugs in clinical trials or that have shown positive results in late-stage studies.
  — Daniel Gilbert, Washington Post, 27 Sep. 2023

Last Updated: 27 Oct 2024